Preclinical murine platform to evaluate therapeutic countermeasures against radiation-induced gastrointestinal syndrome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31551264.
- Also identified by DOI 10.1073/pnas.1906611116 and PMC identifier 6789742.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radiation-induced gastrointestinal syndrome (RIGS) is a limiting factor for therapeutic abdominopelvic radiation and is predicted to be a major source of morbidity in the event of a nuclear accident or radiological terrorism. In this study, we developed an in vivo mouse-modeling platform that enables spatial and temporal manipulation of potential RIGS targets in mice following whole-abdomen irradiation without the confounding effects of concomitant hematopoietic syndrome that occur following whole-body irradiation. We then tested the utility of this platform to explore the effects of transient Wnt pathway activation on intestinal regeneration and animal recovery following induction of RIGS. Our results demonstrate that intestinal epithelial suppression of adenomatous polyposis coli (Apc) mitigates RIGS lethality in vivo after lethal ionizing radiation injury-induced intestinal epithelial damage. These results highlight the potential of short-term Wnt agonism as a therapeutic target and establish a platform to evaluate other strategies to stimulate intestinal regeneration after ionizing radiation damage.
Medical subject headings
- Adenomatous Polyposis Coli Protein
- Gastrointestinal Diseases
- Intestines
- Radiation Injuries, Experimental
- Regeneration
- Whole-Body Irradiation
- Wnt Proteins